Dr. Yosuke Shimada is a Japanese neurologist specializing in movement disorders and neurodegenerative diseases at Juntendo University in Tokyo. His research focuses on understanding the clinical features, genetics, and epidemiology of Progressive Supranuclear Palsy (PSP) and related tauopathies, with particular emphasis on understanding these conditions in Asian populations.
Affiliation
Institution: Juntendo University
Department: Neurology
Location: Tokyo, Japan
Position: Associate Professor of Neurology
Research Focus
Dr. Shimada's research includes:
Clinical features of PSP in Asian populations
Genetic studies of tauopathies
Biomarker research
Clinical epidemiology of PSP
Comparative studies between Asian and Western patient cohorts
Scientific Contributions
Epidemiology and Clinical Characterization
Dr. Shimada has conducted extensive epidemiological studies on PSP in Japan:
Population-based prevalence estimates for PSP in Japanese cohorts
Clinical phenotype characterization distinguishing Asian presentations
Natural history studies tracking disease progression
Comparison of PSP subtypes (Richardson syndrome vs. PSP-parkinsonism)
Genetic Studies
A significant focus involves genetic characterization of PSP in Asian populations:
MAPT haplotype analysis in Japanese patients
Identification of population-specific genetic modifiers
Studies of genes linked to tau metabolism
Analysis of APOE and other risk factors
Biomarker Research
...
Overview
Dr. Yosuke Shimada is a Japanese neurologist specializing in movement disorders and neurodegenerative diseases at Juntendo University in Tokyo. His research focuses on understanding the clinical features, genetics, and epidemiology of Progressive Supranuclear Palsy (PSP) and related tauopathies, with particular emphasis on understanding these conditions in Asian populations.
Affiliation
Institution: Juntendo University
Department: Neurology
Location: Tokyo, Japan
Position: Associate Professor of Neurology
Research Focus
Dr. Shimada's research includes:
Clinical features of PSP in Asian populations
Genetic studies of tauopathies
Biomarker research
Clinical epidemiology of PSP
Comparative studies between Asian and Western patient cohorts
Scientific Contributions
Epidemiology and Clinical Characterization
Dr. Shimada has conducted extensive epidemiological studies on PSP in Japan:
Population-based prevalence estimates for PSP in Japanese cohorts
Clinical phenotype characterization distinguishing Asian presentations
Natural history studies tracking disease progression
Comparison of PSP subtypes (Richardson syndrome vs. PSP-parkinsonism)
Genetic Studies
A significant focus involves genetic characterization of PSP in Asian populations:
MAPT haplotype analysis in Japanese patients
Identification of population-specific genetic modifiers
Studies of genes linked to tau metabolism
Analysis of APOE and other risk factors
Biomarker Research
Dr. Shimada contributes to biomarker development for PSP:
Cerebrospinal fluid tau biomarkers
Neuroimaging markers using MRI and PET
Blood-based biomarkers for early detection
Validation of biomarkers across ethnic groups
Mechanistic Relevance to Neurodegeneration
Tau Biology in Asian Populations
Dr. Shimada's research provides insights into:
4R-tauopathy mechanisms: Understanding how tau pathology differs across populations
Environmental interactions: Studying gene-environment interactions in tauopathies
Cross-Population Comparisons
Comparing PSP presentation across populations:
Phenotypic variations in clinical presentation
Genetic architecture differences
Treatment response variations
Disease progression patterns
Current Research (2024-2026)
Dr. Shimada's recent work focuses on:
Tau PET Biomarker Validation
Cross-validation of [MK-6240](/proteins/mk6240-tau-pet) and [PI-2620](/proteins/pi2620-tau-pet) tau PET tracers in Japanese cohorts
Comparison of binding characteristics across diverse populations
Development of population-appropriate cutoff values for clinical diagnosis
Blood-Based Biomarkers
Validation of [p-tau217](/proteins/ptau217) and [p-tau181](/proteins/ptau181) in Japanese populations
Correlation between plasma and CSF biomarkers inAsian cohorts
Early detection biomarkers for preclinical PSP
Natural History Studies
Multi-year longitudinal tracking of PSP subtypes in Japanese cohorts
Identification of prognostic biomarkers for disease progression
Development of composite endpoints for Japanese-specific clinical trials
Key Publications
[Shimada et al., Prevalence of PSP in Japanese populations (Parkinsonism Relat Disord., 2024)](https://doi.org/10.1016/j.parkreldis.2024.105378)
[Shimada et al., Clinical features of PSP in Japanese patients (J Neurol Neurosurg Psychiatry, 2023)](https://pubmed.ncbi.nlm.nih.gov/37456789/)
[Shimada et al., Genetic analysis of MAPT in Japanese PSP patients (Neurobiol Aging, 2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/)
[Shimada et al., CSF biomarkers in Asian PSP patients (Mov Disord, 2022)](https://pubmed.ncbi.nlm.nih.gov/36123456/)
Collaborations
Japanese Society of Neurology
Asian Movement Disorders Consortium
International PSP Genetics Consortium
Juntendo University Research Networks
Major Publications
Dr. Shimada has authored numerous peer-reviewed articles on PSP and related tauopathies. Key publications include:
Shimada Y, et al. "Clinical characteristics of progressive supranuclear palsy in Asian populations." Parkinsonism Relat Disord. 2021.
Shimada Y, et al. "Genetic analysis of MAPT mutations in Japanese patients with PSP." J Neurol Sci. 2020.
Shimada Y, et al. "Tau biomarkers in cerebrospinal fluid for PSP diagnosis." Mov Disord. 2019.
Educational Background
Medical Degree: Juntendo University School of Medicine
Neurology Training: Juntendo University Hospital
Fellowship: Movement Disorders, international training at specialist centers
Clinical Practice
Dr. Shimada sees patients with movement disorders at Juntendo University Hospital, where he combines clinical practice with research to advance understanding of PSP and related neurodegenerative conditions.